As a result of the patent cliff, generic drug manufacturers have thrived while branded pharmaceutical manufacturers have suffered. Branded pharmaceutical manufacturers are expected to suffer even more in the coming years, as many more important patents will lose exclusivity.
A recent paper from the Centers for Medicare and Medicaid Services delves into these issues and more.
In today’s healthcare ecosystem, it’s much better to partner than to go it alone. This was a key theme at the Drug Store News Industry Issues Summit in New York City, where industry leaders said retailers, providers, payers and technology companies need to work more closely together to improve patient journeys across a range of touchpoints. Read more
The need to bridge the gap between the pharmacy counter and the rest of the retail operation is generating more discussion across the industry at a time of changing consumer attitudes and growing competition from a wider range of retailers — both brick-and-mortar and virtual. Read more
Chronic care management has become an all-consuming topic for retail pharmacy. It has moved beyond a niche industry topic to a high-profile, national conversation that involves healthcare costs, government policy, emerging technologies and, most importantly, daily life for millions of consumers. Read more